PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)(COMPLETED) - Related Studies

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)(COMPLETED)

This study has been completed.

Study NCT00034671. Last updated on May 31, 2006. Information provided by Schering-Plough

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Mycoses

2	Additional conditions recognized in this trial
		Infection

3	Interventions listed in this trial
		Posaconazole oral suspension

4	Additional drug interventions recognized in this trial
		Posaconazole

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antibiotics, Antifungal
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses
		Trypanocidal Agents

6	Sponsors listed in this trial
		Schering-Plough